Login / Signup

A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy.

Charlotte Gotthard MortzLouise ParkeHelene M RasmussenHenrik Fomsgaard KjaerCarsten Bindslev-Jensen
Published in: Allergy (2024)
An increase in the threshold level during Omalizumab treatment significantly improve patient safety and protected all children against small amount of allergen.
Keyphrases
  • patient safety
  • double blind
  • young adults
  • quality improvement
  • clinical trial
  • placebo controlled
  • early onset
  • randomized controlled trial
  • study protocol